MicroRNA 449a can Attenuate Protective Effect of Urokinase Against Pulmonary Embolism
Acute pulmonary embolism (APE) is a disabling diseases with high incidence rate and mortality rate. Although with high specificity, D-Dimer lacks specificity to assess APE, hence additional diagnostic and prognostic biomarkers are necessary. APE is widely treated with serine protease urokinase or ur...
Main Authors: | Ran Zhu, Wei-yi Qi, Ting-wei Liu, Fan Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.713848/full |
Similar Items
-
Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
by: Ran Zhu, et al.
Published: (2022-08-01) -
Inhibitors of Urokinase Type Plasminogen Activator and Cytostatic Activity from Crude Plants Extracts
by: Augusto Carvajal, et al.
Published: (2013-07-01) -
Urokinase System in Pathogenesis of Pulmonary Fibrosis: A Hidden Threat of COVID-19
by: Anna A. Shmakova, et al.
Published: (2023-01-01) -
Monitoring of chemotherapy successfulness of Platina/Taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FIGO II
by: Dženita Ljuca, et al.
Published: (2007-05-01) -
The Dynamics of miR-449a/c Expression during Uterine Cycles Are Associated with Endometrial Development
by: Mladen Naydenov, et al.
Published: (2022-12-01)